# Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients Undergoing Liver Resection

> **NCT01596283** · PHASE3 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 135 (actual)

## Conditions studied

- Liver Cancer

## Interventions

- **PROCEDURE:** Standard fluid management
- **DEVICE:** Goal directed fluid therapy with the Edwards EV1000 system

## Key facts

- **NCT ID:** NCT01596283
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 135 (ACTUAL)
- **Last updated:** 2017-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01596283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01596283, "Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients Undergoing Liver Resection". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01596283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*